Suppr超能文献

人乳头瘤病毒感染与宫颈上皮内瘤变女性宫颈管腺上皮受累的关系。

The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.

机构信息

Department of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Italy.

Department of Pathology, Fondazione IRCCS Policlinico San Matteo, Università of Pavia, Italy.

出版信息

Gynecol Oncol. 2020 Dec;159(3):630-635. doi: 10.1016/j.ygyno.2020.09.034. Epub 2020 Oct 9.

Abstract

OBJECTIVE

The aim of study was to evaluate the association of endocervical gland involvement (EGI) on histological samples with high risk (HR) human papillomavirus (HPV) infection and with the persistence/recurrence rate of cervical intraepithelial neoplasia (CIN) after treatment.

METHODS

A total of 1301 subjects who had conization procedures after cervical punch biopsies (533 persistent CIN1, 768 CIN2+ including 20 microinvasive cervical cancer) were enrolled in the study. HPV genotypes were identified using the INNO-LiPA HPV genotyping assay on cervical scraping. Logistic regression and Cox regression analyses were used to evaluate the association of EGI on the persistence/recurrence rate of CIN after treatment.

RESULTS

The rate of EGI on final histology was 46.3% (602/1301). HPV 16 was the only HR-HPV significantly associated with increasing rates of EGI (231/602 as compared to 211/699, p = 0.002). EGI was also associated with an excess of multiple HR-HPV infections (237/602 as compared with 225/699, p = 0.006). After correction for confounders, the odds ratio of EGI among women infected by HPV 16 was 1.41 (95% CI = 1.12-178). CIN2+ lesions were diagnosed in 40.5% (283/699) of EGI negative subjects and 86.7% (522/602, p < 0.001 compared to negative subjects) of EGI positive subjects.After a median of 25 months of follow-up (IQR = 15-47) of 1090 treated women, the persistence of HPV 16 during follow-up was 38.1% (93/217, p = 0.03 compared to EGI negative) among EGI positive and 32% (58/181) among controls. After corrections for potential confounders, the odds ratio of CIN2+ persistence and or recurrence was higher among EGI positive (OR = 2.35, 95% CI = 1.16-4.77) than negative controls.

CONCLUSION

EGI on histological samples is associated with increased rates of HPV 16, multiple high risk-HPV infections and CIN2+ lesions. EGI positive subjects also had an increased CIN recurrence/persistence after treatment compared to controls.

摘要

目的

本研究旨在评估宫颈内膜腺上皮累及(endocervical gland involvement,EGI)与高危型(high risk,HR)人乳头瘤病毒(human papillomavirus,HPV)感染及宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN)治疗后持续性/复发率之间的相关性。

方法

本研究共纳入 1301 例因宫颈穿刺活检后行宫颈锥切术的患者(533 例持续性 CIN1,768 例 CIN2+,包括 20 例微浸润宫颈癌)。采用 INNO-LiPA HPV 基因分型检测试剂盒对宫颈刮片标本进行 HPV 基因型鉴定。采用 logistic 回归和 Cox 回归分析评估 EGI 与治疗后 CIN 持续性/复发率之间的相关性。

结果

最终组织学检查 EGI 发生率为 46.3%(602/1301)。HPV16 是唯一与 EGI 发生率增加显著相关的 HR-HPV(231/602 例与 211/699 例相比,p=0.002)。EGI 也与 HR-HPV 多重感染的发生率增加有关(237/602 例与 225/699 例相比,p=0.006)。校正混杂因素后,HPV16 感染女性中 EGI 的比值比为 1.41(95%CI=1.12-178)。EGI 阴性患者中 CIN2+病变的检出率为 40.5%(283/699),而 EGI 阳性患者中 CIN2+病变的检出率为 86.7%(522/602,p<0.001 与阴性患者相比)。在中位随访 25 个月(IQR=15-47)后,1090 例治疗后的女性中,EGI 阳性患者的 HPV16 持续性感染率为 38.1%(93/217,p=0.03 与 EGI 阴性患者相比),而对照组为 32%(58/181)。校正潜在混杂因素后,EGI 阳性患者的 CIN2+持续性或复发的比值比高于阴性对照组(OR=2.35,95%CI=1.16-4.77)。

结论

组织学标本上的 EGI 与 HPV16 感染率增加、HR-HPV 多重感染和 CIN2+病变有关。与对照组相比,EGI 阳性患者在治疗后 CIN 的复发/持续性也更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验